175 related articles for article (PubMed ID: 26158902)
1. IRX1 hypomethylation in osteosarcoma metastasis.
Lu J; Wang J
Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
[No Abstract] [Full Text] [Related]
2. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
Shen A; Zhang Y; Yang H; Xu R; Huang G
J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Huang JF; Du WX; Chen JJ
J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
[TBL] [Abstract][Full Text] [Related]
6. EMP1 promotes the malignant progression of osteosarcoma through the IRX2/MMP9 axis.
Wang M; Liu T; Hu X; Yin A; Liu J; Wang X
Panminerva Med; 2020 Sep; 62(3):150-154. PubMed ID: 32716150
[TBL] [Abstract][Full Text] [Related]
7. CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.
Wen M; Ren H; Zhang S; Li T; Zhang J; Ren P
Cell Death Dis; 2021 Jun; 12(7):650. PubMed ID: 34172717
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of Iroquois homeobox 1 methylation in non-small cell lung cancers.
Lee JY; Lee WK; Park JY; Kim DS
Genes Genomics; 2020 May; 42(5):571-579. PubMed ID: 32200543
[TBL] [Abstract][Full Text] [Related]
10. Identification of co-expression modules and pathways correlated with osteosarcoma and its metastasis.
Wang JS; Wang YG; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
World J Surg Oncol; 2019 Mar; 17(1):46. PubMed ID: 30849987
[TBL] [Abstract][Full Text] [Related]
11. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.
Cao Y; Zhou Z; de Crombrugghe B; Nakashima K; Guan H; Duan X; Jia SF; Kleinerman ES
Cancer Res; 2005 Feb; 65(4):1124-8. PubMed ID: 15734992
[TBL] [Abstract][Full Text] [Related]
12. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
[TBL] [Abstract][Full Text] [Related]
13. Characterizing biomarkers in osteosarcoma metastasis based on an ego-network.
Liu Z; Song Y
Biotechnol Lett; 2017 Jun; 39(6):841-848. PubMed ID: 28229297
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
15. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Barøy T; Kresse SH; Skårn M; Stabell M; Castro R; Lauvrak S; Llombart-Bosch A; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2014 Apr; 13():93. PubMed ID: 24885297
[TBL] [Abstract][Full Text] [Related]
16. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.
Liu Y; Guan J; Chen X
Pathol Oncol Res; 2019 Jul; 25(3):1091-1102. PubMed ID: 30411296
[TBL] [Abstract][Full Text] [Related]
17. Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma.
Chang H; Dong T; Ma X; Zhang T; Chen Z; Yang Z; Zhang Y
Biochem Biophys Res Commun; 2015 Aug; 464(1):45-50. PubMed ID: 26032498
[TBL] [Abstract][Full Text] [Related]
18. Identification of key biomarkers involved in osteosarcoma using altered modules.
Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
[TBL] [Abstract][Full Text] [Related]
19. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
Wang Q
Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
[TBL] [Abstract][Full Text] [Related]
20. HER-2 involvement in osteosarcoma.
Gill J; Geller D; Gorlick R
Adv Exp Med Biol; 2014; 804():161-77. PubMed ID: 24924174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]